New pill shows promise for bipolar depression in major trial
NCT ID NCT02600494
First seen Nov 03, 2025 · Last updated Apr 30, 2026 · Updated 22 times
Summary
This study tested a new medication called ITI-007 (lumateperone) to see if it can safely ease depression in people with bipolar I or II disorder. About 550 adults took either the drug or a placebo for six weeks. Researchers measured mood changes using a standard depression scale. The goal was to find a new treatment option for bipolar depression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site
Little Rock, Arkansas, United States
-
Clinical Site
Rogers, Arkansas, United States
-
Clinical Site
Cerritos, California, United States
-
Clinical Site
Culver City, California, United States
-
Clinical Site
Garden Grove, California, United States
-
Clinical Site
Lemon Grove, California, United States
-
Clinical Site
National City, California, United States
-
Clinical Site
Oakland, California, United States
-
Clinical Site
Oceanside, California, United States
-
Clinical Site
Orange, California, United States
-
Clinical Site
Pico Rivera, California, United States
-
Clinical Site
Riverside, California, United States
-
Clinical Site
San Diego, California, United States
-
Clinical Site
San Marcos, California, United States
-
Clinical Site
Santa Rosa, California, United States
-
Clinical Site
Colorado Springs, Colorado, United States
-
Clinical Site
Bradenton, Florida, United States
-
Clinical Site
Fort Myers, Florida, United States
-
Clinical Site
Jacksonville, Florida, United States
-
Clinical Site
Lauderhill, Florida, United States
-
Clinical Site
Miami, Florida, United States
-
Clinical Site
North Miami, Florida, United States
-
Clinical Site
Orlando, Florida, United States
-
Clinical Site
Atlanta, Georgia, United States
-
Clinical Site
Chicago, Illinois, United States
-
Clinical Site
Hoffman Estates, Illinois, United States
-
Clinical Site
Lake Charles, Louisiana, United States
-
Clinical Site
Baltimore, Maryland, United States
-
Clinical Site
Boston, Massachusetts, United States
-
Clinical Site
O'Fallon, Missouri, United States
-
Clinical Site
St Louis, Missouri, United States
-
Clinical Site
Las Vegas, Nevada, United States
-
Clinical Site
Berlin, New Jersey, United States
-
Clinical Site
Cherry Hill, New Jersey, United States
-
Clinical Site
Marlton, New Jersey, United States
-
Clinical Site
Toms River, New Jersey, United States
-
Clinical Site
Brooklyn, New York, United States
-
Clinical Site
Cedarhurst, New York, United States
-
Clinical Site
New York, New York, United States
-
Clinical Site
Rochester, New York, United States
-
Clinical Site
Staten Island, New York, United States
-
Clinical Site
Cincinnati, Ohio, United States
-
Clinical Site
Cleveland, Ohio, United States
-
Clinical Site
Dayton, Ohio, United States
-
Clinical Site
Garfield Heights, Ohio, United States
-
Clinical Site
Oklahoma City, Oklahoma, United States
-
Clinical Site
Allentown, Pennsylvania, United States
-
Clinical Site
Norristown, Pennsylvania, United States
-
Clinical Site
Philadelphia, Pennsylvania, United States
-
Clinical Site
Memphis, Tennessee, United States
-
Clinical Site
Austin, Texas, United States
-
Clinical Site
Dallas, Texas, United States
-
Clinical Site
Houston, Texas, United States
-
Clinical Site
Petersburg, Virginia, United States
-
Clinical Site
Everett, Washington, United States
Conditions
Explore the condition pages connected to this study.